Color Doppler Eye Ultrasonography in giant cell arteritis: differential diagnosis between arteritic and non-arteritic sudden blindness

[1]  B. Long,et al.  Diagnostic accuracy of the history, physical examination, and laboratory testing for giant cell arteritis , 2020, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[2]  C. Montecucco,et al.  Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse , 2020, Frontiers in Medicine.

[3]  A. Tomelleri,et al.  Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool. , 2020, RMD open.

[4]  S. Jousse-Joulin,et al.  Temporal Artery Ultrasound to Diagnose Giant Cell Arteritis: A Practical Guide. , 2020, Ultrasound in medicine & biology.

[5]  B. Frediani,et al.  The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis , 2020, Mediators of inflammation.

[6]  A. Tomelleri,et al.  Probability-based algorithm using ultrasound and additional tests for suspected GCA in a fast-track clinic , 2020, RMD open.

[7]  M. Guevara,et al.  Use of Ultrasound in the Diagnosis and Management of the Vasculitides , 2020, Current Rheumatology Reports.

[8]  R. Luqmani,et al.  Diagnosis of giant cell arteritis. , 2020, Rheumatology.

[9]  R. Luqmani,et al.  Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia , 2020, Annals of the rheumatic diseases.

[10]  R. Luqmani,et al.  The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist , 2018, Rheumatology.

[11]  Eric L Matteson,et al.  Large-vessel giant cell arteritis: diagnosis, monitoring and management , 2018, Rheumatology.

[12]  J. Liddle,et al.  Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis , 2017, BMC Medicine.

[13]  D. Mackey,et al.  Giant cell arteritis: ophthalmic manifestations of a systemic disease , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  M. Kaps,et al.  Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion , 2015, Stroke.

[15]  B. Dasgupta,et al.  Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. , 2015, Clinical and experimental rheumatology.

[16]  U. Bogdahn,et al.  The Retrobulbar “Spot Sign” as a Discriminator Between Vasculitic and Thrombo-Embolic Affections of the Retinal Blood Supply , 2012, Ultraschall in der Medizin.

[17]  E. Eggenberger,et al.  Diagnosis and management of giant cell arteritis: a review , 2010, Current opinion in ophthalmology.

[18]  R. Sergott,et al.  Embolic central retinal artery occlusion detected by orbital color Doppler imaging. , 2002, Ophthalmology.

[19]  S. Hayreh,et al.  Ocular manifestations of giant cell arteritis. , 1998, American journal of ophthalmology.

[20]  G. Haugeberg,et al.  The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? , 2016, Rheumatology.

[21]  A. Arnold.  Ischemic optic neuropathies. , 2001, Ophthalmology clinics of North America.

[22]  P. Speiser,et al.  Indocyanine green versus fluorescein angiography in the differential diagnosis of arteritic and nonarteritic anterior ischemic optic neuropathy. , 1999, Retina.

[23]  T. Williamson,et al.  Colour doppler imaging in giant cell (temporal) arteritis: Serial examination and comparison with non-arteritic anterior ischaemic optic neuropathy , 1996, Eye.